Anti-VEGF Receptor 2 antibody [KDR/EIC] (ab9530)

ab9530 has been referenced in 10 publications.

• Uehara H  et al. Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J : (2012). Flow Cyt . PubMed: 22997228
• Kuliszewski MA  et al. Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles. Cardiovasc Res 83:653-62 (2009). IHC-Fr ; Rat . PubMed: 19564152
• Gheisari Y  et al. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy 10:815-23 (2008). Flow Cyt ; Rat . PubMed: 19058061
• Marimpietri D  et al. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin Cancer Res 13:3977-88 (2007). PubMed: 17606732
• Shintani Y  et al. Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 25:3045-55 (2006). PubMed: 16763549
• Sigurdsson V  et al. Human breast microvascular endothelial cells retain phenotypic traits in long-term finite life span culture. In Vitro Cell Dev Biol Anim 42:332-40 (2006). PubMed: 17316068
• Gampel A  et al. VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment. Blood 108:2624-31 (2006). PubMed: 16638931
• Williams CK  et al. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 107:931-9 (2006). Flow Cyt ; Human . PubMed: 16219802
• Murga M  et al. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood 105:1992-9 (2005). Flow Cyt ; Human . PubMed: 15522955
• Scarlato M  et al. Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis. Brain 128:1911-20 (2005). ICC/IF ; Human . PubMed: 15975949